Skip to main content

Precision Medicine Market Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2021–2026

 

Global Precision Medicine Market is expected to reach the market valuation of US$ 105.64 billion by 2026 expanding at a reasonable CAGR of 9.95% during the forecast period (2021-2026) from US$ 58.66 billion in 2019. Development in precision medicine is occurring at an owing to the effectiveness of this medication. Government bodies such as research institutes and hospitals are also taking part for its development.

Healthcare is changing rapidly. Several technologies are being introduced every year to decrease the mortality rate. Currently, a transition has been witnessed from the traditional reactive medicine that was based on symptoms, diagnosis and treatment to a system that targets the disease much earlier it occurs. Precision Medicine is that new way of thinking. The major principles on which the precision medicine is based involves prediction, prevention, personalization, and participation. The growing attention toward precision medicine is directed by a fundamental shift from the ‘one size fits all’ paradigm for treatment of patients with conditions or predisposition to diseases. Driven by these, numerous national as well as international genome projects have been initiated to reap the benefits of precision medicine.

Request for Sample of the report browse through- https://univdatos.com/request_form/form/331

According to an analysis, the topmost 10 highest-grossing drugs in the U.S. merely help between 1 in 4 to 1 in 25 of the patients who administer them. This estimate highlights the lack of specificity for the drugs that are in currently in use and provides the opportunity that exists for highly targeted precision medicines. Gene sequencing is a major part of precision medicine as it is genome based. Advances in next generation sequencing (NGS) technologies have resulted in an exceptional proliferation and surge of genomic sequence data.

Precision medicine is not only based on pharmacology. There are numerous components of this type of medicine as they are highly specific to the genome of a group of individuals. Big data analytics, bioinformatics, gene sequencing, drug discovery, companion diagnostics, and others are some of the technologies that are required for the precision medicine development. Bioinformatics and gene sequencing are required for producing genomic data, as genomic data is necessary for the drug development. Big data analytics is used for the analysis of the data produced. Oncology, respiratory diseases, central nervous system disorders, immunology and genetic diseases are some of the mostly studied diseases in this area. More than 50% of the precision medicine research is done on oncology, as it is one of the burning topics in healthcare.

For a detailed analysis of the automation in Precision Medicines browse through - https://univdatos.com/report/precision-medicine-market-current-analysis-and-forecast-2020-2026 

There are several end-users of precision medicine. hospitals & clinics, pharmaceuticals, diagnostic companies, Healthcare-IT firms, and others are some of the major end users. Pharmaceutical companies are developing precision medicine by collaborating with several players. Amgen, a leading biotechnology company and Syapse announced a precision medicine collaboration in oncology. These collaborations act as the ‘X factor’ for the thriving industry. Genomic sequencing also plays a crucial part in precision medicine development as genomic sequencing and biomedical informatics in the laboratory plays an important role in reporting and decision support to the patients.

Additionally, the report provides detailed initiatives that are being taken in the field of precision medicine. The market is classified into distinct regions including North America (U.S and Canada), Europe (Germany, France, Spain, Italy, and United Kingdom), Asia-Pacific (China, Japan, India, and Australia) and rest of the world. United States generated revenue of US$ 17.9 billion in 2019. However, APAC region is expected to witness the highest CAGR growth of 11.27% during the forecast period 2020-2026.

Hoffmann-La Roche, Eli Lilly and Company, NeoGenomics Laboratories, Novartis, Teva Pharmaceutical, Thermo Fisher Scientific, Quest Diagnostics, Abbott Laboratories, NanoString Technologies, and AstraZeneca are some of the prominent players operating in the global precision medicine market. Several M&A’s along with partnerships have been undertaken by these players to develop precision medicine.

Global Precision Medicine Market Segmentation

Market Insight, by Technology Type

Big Data Analytics

Bioinformatics

Gene Sequencing

Drug Discovery

Companion Diagnostics

Other Products

Market Insight, by Application

Oncology

Respiratory Diseases

Central Nervous System Disorder

Immunology

Genetic Diseases

Others

Market Insight, by End-User

Hospitals & Clinics

Pharmaceuticals

Diagnostic Companies

Healthcare-IT Firms

Others

Market Insight, by Region

North America

United States

Canada

Rest of North America

Europe

Italy

Spain

France

Germany

United Kingdom

Rest of Europe

Asia-Pacific

China

Japan

India

Australia

Rest of Asia-Pacific

Rest of World

Top Company Profiles

Hoffmann-La Roche

Medtronic

Qiagen

Illumina

Abbott Laboratories

GE Healthcare

NanoString Technologies

BioMérieux SA

Danaher Corporation

AstraZeneca

Feel free to contact us for any queries – https://univdatos.com/request_form/form/331

The precision Medicine Market can further be customized as per the requirement or any other market segment. Besides this, UMI understands that you may have your own business needs, hence feel free to connect with us to get a report that completely suits your requirements.

UnivDatos Market Insights (UMI) Latest Research Report –

Plant-Based Food Market — Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2019–2025

Frozen Food Market — Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2020

Hand Sanitizer Market Size Worth US$ 15.3 Billion by 2026

Critical Care Equipment Market to Reach US$ 38 Billion by 2026

About Us:

UnivDatos Market Insights (UMI), is a passionate market research firm and a subsidiary of Universal Data Solutions. Rigorous secondary and primary research on the market is our USP, hence information presented in our reports is based on facts and realistic assumptions. We have worked with 200+ global clients, including some of the fortune 500 companies. Our clientele praises us for quality of insights, In-depth analysis, custom research abilities and detailed market segmentation.

Contact us:

UnivDatos Market Insights (UMI)

Email: sales@univdatos.com

Web: https://univdatos.com

Ph: +91 7838604911

Labels:
Location: Europe

Comments

Post a Comment

Popular posts from this blog

Infant Formula Ingredients Market: Analysis by Size, Share, Growth, Trends & Forecast 2027

  Booming Baby Food Market: Infant Formula Ingredients on the Rise! The infant formula ingredients market is on a healthy trajectory, expected to reach a value of USD 42.3 billion by 2030, with a growth rate of around 8.6%. This surge is driven by several factors: Heightened awareness of infant health: Parents are increasingly prioritizing the well-being of their babies, leading to a demand for high-quality infant formula ingredients. Innovation for gold-standard nutrition: Manufacturers are constantly developing new ingredients that mimic breast milk's properties, like Bunge Loders Croklaan's Betapol Select lipid ingredient. Growing toddler formula market: Brands like Danone Nutricia are catering to toddlers with specialized formulas made with unique ingredients like sheep milk. Unlock Insights: Receive a Sample Research Report on the Infant Formula Ingredients Market: https://univdatos.com/get-a-free-sample-form-ph...
Post a Comment
Read more

Renewable Energy Certificate Market: Analysis by Size, Share, Growth, Trends & Forecast 2030

  Renewable Energy Certificates: Powering a Sustainable Future The Renewable Energy Certificate (REC) market is surging, expected to reach a value of USD 87.2 billion by 2030 at a CAGR of 26.39%. This growth is fueled by a global shift towards clean energy: Government Policies: Governments worldwide are implementing policies and incentives to promote renewable energy and RECs as a way to achieve sustainability goals. Climate Change Concerns: Growing awareness of climate change is driving demand for cleaner energy sources and RECs as a way to offset carbon footprints. Technological Advancements: Advances in renewable energy technology have made it more cost-effective, reducing REC prices and making them a viable option for businesses and consumers. Sustainability-Conscious Consumers: Consumers are increasingly seeking products and services that align with their eco-friendly values, boosting the voluntary REC mar...
Post a Comment
Read more

Generator Sets Market: Analysis by Size, Share, Growth, Trends & Forecast 2027

  Power Up for the Future: Generator Set Market Expected to Surge The generator set market is powering forward, with a projected growth rate of 7.5% to reach a value of USD 40.6 billion by 2030. This surge is fueled by several key trends: Rising Demand for Backup Power: Unreliable power grids and remote locations are driving the need for emergency backup solutions. Companies like Caterpillar are catering to this need with new household and commercial generators. Market Leaders and Trends: Diesel Dominates: Diesel is expected to hold the largest market share due to its stability, high energy density, and efficient fuel consumption. Portables Take Center Stage: Generators below 75 kVA are projected to lead the market, driven by the booming construction industry in regions like India and China. Commercial Boom: The commercial sector is expected to see the fastest growth due to government initiatives promoting...
Post a Comment
Read more